Omnicare Beats Contaminated-Drug FCA Suit

Law360, Washington (August 15, 2012, 1:22 PM EDT) -- A Maryland federal judge dismissed a whistleblower False Claims Act case against Omnicare Inc. on Tuesday that alleged the company violated U.S. Food and Drug Administration regulations by selling contaminated drugs to the government, saying there wasn't enough information to prove fraudulent acts had been committed.

While U.S. District Judge Catherine C. Blake rejected Omnicare's claims that the court doesn't have jurisdiction over former Omnicare employee Barry Rostholder's qui tam case, she noted that Rostholder didn't provide enough information to determine if any fraudulent action had...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

United States of America, ex rel Barry Rostholder v Omnicare, Inc. et al


Case Number

1:07-cv-01283

Court

Maryland

Nature of Suit

Other Statutory Actions

Judge

Catherine C. Blake

Date Filed

May 15, 2007

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.